Developer docs
API playgroundTry for free, no card

Search company profiles

Jade

Full company profile

uuid000uzuc

Namestring
Jade
Legal namestring
Jade Diabetes Pty Ltd
Company typeenum
Private
Founded yearint
2012
Descriptiontext

Jade Diabetes Pty Ltd (operating as Jade, formerly PredictBGL and ManageBGL) is a privately held Melbourne-based software company founded in 2012 by the founders of DataMystic. It develops a smartphone insulin-dosing application for people with insulin-dependent diabetes (Type 1, Type 1.5/LADA, Type 2, and Gestational), powered by a proprietary AI blood-glucose prediction engine adapted from closed-loop artificial pancreas algorithms and applied to multiple daily injection therapy. The core product tracks 64 types of diabetes data, integrates with Dexcom and Abbott FreeStyle Libre continuous glucose monitors, NightScout, connected glucometers (including iHealth), food databases (5 million items via MyFitnessPal, CalorieKing, FatSecret), fitness devices, period and pain trackers, and digital insulin pens, while offering personalized coaching, gamification, hypo/hyper alerts, and a Tele Health workflow.

The platform extends beyond the consumer app into CamperView Remote Patient Monitoring for endocrinologists, diabetes educators, and schools, an Amazon Alexa voice skill, an Open API supporting 60+ diabetic devices and legacy systems, and a web portal for healthcare professional research and triage. The app achieved Class 1 Medical Device regulation by FDA/TGA in August 2023, with data hosted on AWS infrastructure aligned to HIPAA, SOC 1/2/3, PCI DSS Level 1, ISO 27001, FedRAMP, FISMA, and ITAR standards.

Jade operates a freemium-to-subscription model: a free trial converts into recurring subscription revenue from individuals, with emerging coverage from healthcare providers who prescribe the app and payers/insurers who cover it for eligible patients. Go-to-market is primarily product-led via Apple App Store and Google Play self-serve downloads, supplemented by healthcare-provider referrals, content marketing, social media, and email. The platform reports a user base of 25,000-43,000+ people with diabetes globally, with only one disclosed institutional capital event (a 2020 500 Global investment) and a headcount in the 11-50 range.

Short descriptiontext

Jade Diabetes is a Melbourne-based software company whose mobile app provides AI-driven insulin dose calculations, multi-hour blood-glucose predictions, and personalized coaching for people with insulin-dependent diabetes, integrating with CGMs, food, fitness and health-tracking apps.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMount Waverley, Australia
HQ citystring
Mount Waverley
HQ countrystring
Australia
HQ regionstring
Oceania
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
insulin dose calculation, blood glucose prediction, diabetes management software, continuous glucose monitoring, remote patient monitoring
Industry3 codes
PRIMARYHLAHAHAJ
Diabetes Digital Therapeutics & Dose Decision Support (Bolus Calculators)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Diabetes Care Devices (CGM, Insulin Delivery)
SECONDARYHLALAGAD
Endocrinology & Diabetes Telemedicine Platforms
Healthcare & Life Sciences/Telehealth Platforms/Specialty Telemedicine Platforms (e.g., dermatology, cardiology, neurology)
SECONDARYHLALAFAF
Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
NAICS code1 code
  • Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services5182
SIC code1 code
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
Diabetes Management Software
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1App Subscription (Freemium with Free Trial)
TypeSubscription Recurring
Description

The service offers a FREE trial period, followed by subscription-based access to the full Jade Diabetes app with premium features including advanced dose calculations, predictions, coaching, and unlimited device sync. The company generates recurring subscription revenue from individuals, healthcare providers, and payers (insurance companies) who cover the app for patients.

jadediabetes.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations
Pricing details1 tier
1Free Trial Period
ModelFreemiumBilling cadenceMonthly
Notes

Free trial available before subscription conversion

jadediabetes.com
GTM typeB2B and B2C
B2B and B2C
Offering typeSoftware
Software
Brand1 record
1Jade
Description

Main diabetes management app brand providing insulin dosing calculations, blood glucose predictions, and coaching for people with Type 1, Type 1.5, Type 2, Gestational, and LADA diabetes

jadediabetes.com
Core offering1 text field

Jade Diabetes provides a smartphone insulin dosing app that calculates insulin doses, predicts blood glucose levels hours ahead (with 87% accuracy up to three hours ahead), and offers coaching for people with insulin-dependent diabetes (Type 1, LADA/Type 1.5, Type 2, Gestational). It integrates live data from continuous glucose monitors (Dexcom, FreeStyle Libre, NightScout), connected glucometers, food apps covering 5 million foods, fitness devices, digital insulin pens, period trackers, and pain trackers. The platform uses the same algorithms as closed-loop artificial pancreas systems but applies them to multiple daily injection therapy, with companion modules for healthcare provider remote patient monitoring (CamperView), Alexa voice control, telehealth, an open developer API, and a points-based gamification system.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 87% accurate blood glucose predictions up to three hours ahead
+2 more records
Product overview1 text field

Jade Diabetes is a unified diabetes management platform centered on a smartphone insulin dosing app (formerly PredictBGL and ManageBGL) that provides dose calculations and blood glucose predictions using closed-loop artificial pancreas algorithms applied to multiple daily injection therapy. The platform operates as a single product with integrated modules including CamperView (Remote Patient Monitoring), an Alexa voice skill, Tele Health consultation support, an Open API for device integrations, a Points System for gamification, and iHealth device connectivity. Available for both iOS and Android smartphones and tablets with live data sync between unlimited devices.

Product and service4 records
1Jade Diabetes App
CategoryConsumer diabetes management app
Description

Smartphone insulin dosing app (iOS and Android) for people with insulin-dependent diabetes (Type 1, Type 1.5/LADA, Type 2, Gestational). Provides dose calculations using insulin-on-board tracking, AI-powered blood glucose predictions up to three hours ahead, hypo/hyper alerts, food logging across 5 million foods, coaching with gamification, and live integration with Dexcom, FreeStyle Libre, NightScout, connected glucometers, fitness devices, digital insulin pens, period trackers, and pain trackers via Apple HealthKit.

2CamperView Remote Patient Monitoring
CategoryHealthcare provider remote patient monitoring
Description

Enterprise remote patient monitoring module that lets healthcare providers, clinics, schools, and camp staff view patient diabetes data live. Supports in-patient, clinic, and school camp care with extensive reporting, population-level statistics, and patient triage capabilities. Targets endocrinologists, diabetes educators, school nurses, and clinicians running diabetes camps.

3Jade Diabetes Portal
CategoryHealthcare provider web portal
Description

Web portal that supports remote patient monitoring and clinical research by healthcare professionals, with extensive reporting, population statistics, and patient triage capabilities. Companion to the mobile app for clinical use cases.

4Jade API
CategoryDeveloper / integration API
Description

Open developer API that enables import from over 60 diabetic devices and legacy diabetes management systems, and allows developers to build vendor applications integrating mobile health apps and devices. Supports remote patient monitoring and clinical research use cases.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
Strategic tierCoreTypeTechnology or Integration
Description

Dexcom CGM integration allowing live blood glucose data streaming into Jade Diabetes. Supports Dexcom G7, G6, G5, G4 with Share. Five-minute blood sugar data is seamlessly integrated for dosing calculations and predictions.

2Abbott (FreeStyle Libre)
Strategic tierCoreTypeTechnology or Integration
Description

FreeStyle Libre CGM integration with support for FreeStyle Libre, FreeStyle Libre 2 using LibreLink. Data seamlessly integrated into the Jade platform for continuous monitoring.

jadediabetes.com
Strategic tierCoreTypeTechnology or Integration
Description

NightScout open-source artificial pancreas system integration. Data from the NightScout system is accepted to allow integration with APS (Open Source Artificial Pancreas).

4Apple Health
Strategic tierCoreTypeTechnology or Integration
Description

Apple Health integration allowing point-in-time data from connected glucometers, fitness devices, food apps, and insulin data sources via HealthKit on iPhone.

jadediabetes.com
5Amazon Alexa
Strategic tierCoreTypeTechnology or Integration
Description

Amazon Alexa voice assistant integration allowing users to manage diabetes with voice commands through the Jade Alexa skill.

jadediabetes.com
Strategic tierSupportingTypeTechnology or Integration
Description

Food app integration for precise carbohydrate, protein, fat and fiber data from 5 million foods for accurate dose calculations.

Strategic tierSupportingTypeTechnology or Integration
Description

Food database integration for carbohydrate counting and nutrition data from CalorieKing food database.

Strategic tierSupportingTypeTechnology or Integration
Description

Food app integration providing nutrition data integration for meal logging and dose calculations.

Strategic tierSupportingTypeTechnology or Integration
Description

iHealth iBG5s Bluetooth blood glucose meter integration for wireless data sync with Jade Diabetes app.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Subscription-based diabetes management app with coaching, CGM data integration, and a direct-to-consumer hardware glucometer offering. Competes with Jade for self-pay T1D/T2 insulin users willing to pay for premium features.

TypeBroad incumbent
Description

Largest CGM manufacturer with companion apps (Dexcom Clarity, Follow app) that increasingly add dose guidance. As Jade's primary data source, Dexcom is both partner and a potential competitive threat should it extend prediction features natively.

TypeBroad incumbent
Description

Leading tubeless insulin pump maker whose Omnipod 5 AID system includes SmartBolus calculator and trend-based dose adjustments. Represents the closed-loop alternative to Jade's MDI positioning and the most direct premium substitute for users who can afford pump therapy.

TypeDirect peer
Description

Diabetes data management platform that aggregates data from 95+ devices and serves both consumers and healthcare providers via Mobile Insulin Dosing System (MIDS). Comparable in its multi-device integration strategy and healthcare-provider RPM focus.

TypeDirect peer
Description

Chronic condition management platform with a diabetes-focused product line including connected glucometer hardware, app-based coaching, and B2B payer contracts. Comparable in its subscription-plus-coaching model and employer/payer go-to-market.

TypeDirect peer
Description

Nonprofit diabetes data platform supporting multiple pumps and CGMs with clinician-facing analytics. Comparable integration breadth and provider focus, though positioned as a data platform rather than a consumer dose calculator.

7Sugarmate
TypeDirect peer
Description

Tandem Diabetes Care-owned CGM companion app providing visualization, alerts, and Siri/Tidepool integration. Competes directly with Jade's CGM-data interpretation layer, though lacks Jade's predictive AI bolus engine.

TypeDirect peer
Description

Diabetes management app offering logging, bolus estimation, and coaching. Acquired by Roche in 2017, it is the most direct competitor in the consumer diabetes dose-tracking space and overlaps heavily with Jade's MDI user base.

9Diabetes:M
TypeDirect peer
Description

Mobile diabetes management app offering logging, bolus calculation, and reports on iOS/Android. Smaller scale direct peer in the consumer dose-tracking category with comparable freemium model.

10Abbott (FreeStyle Libre)
TypeBroad incumbent
Description

Second-largest CGM manufacturer whose LibreLink app provides glucose data visualization and trend analysis. Similar competitive overlap as Dexcom; LibreLinkUp family app targets the same caregiver use case as Jade's parent-monitoring features.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

Integration15 records

Each record includes

Title, Type, Description, Source

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance13 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Jade

Diabetes Management Softwarejadediabetes.com

Jade Diabetes is a Melbourne-based software company whose mobile app provides AI-driven insulin dose calculations, multi-hour blood-glucose predictions, and personalized coaching for people with insulin-dependent diabetes, integrating with CGMs, food, fitness and health-tracking apps.

What Jade does

Jade Diabetes Pty Ltd (operating as Jade, formerly PredictBGL and ManageBGL) is a privately held Melbourne-based software company founded in 2012 by the founders of DataMystic. It develops a smartphone insulin-dosing application for people with insulin-dependent diabetes (Type 1, Type 1.5/LADA, Type 2, and Gestational), powered by a proprietary AI blood-glucose prediction engine adapted from closed-loop artificial pancreas algorithms and applied to multiple daily injection therapy. The core product tracks 64 types of diabetes data, integrates with Dexcom and Abbott FreeStyle Libre continuous glucose monitors, NightScout, connected glucometers (including iHealth), food databases (5 million items via MyFitnessPal, CalorieKing, FatSecret), fitness devices, period and pain trackers, and digital insulin pens, while offering personalized coaching, gamification, hypo/hyper alerts, and a Tele Health workflow.

The platform extends beyond the consumer app into CamperView Remote Patient Monitoring for endocrinologists, diabetes educators, and schools, an Amazon Alexa voice skill, an Open API supporting 60+ diabetic devices and legacy systems, and a web portal for healthcare professional research and triage. The app achieved Class 1 Medical Device regulation by FDA/TGA in August 2023, with data hosted on AWS infrastructure aligned to HIPAA, SOC 1/2/3, PCI DSS Level 1, ISO 27001, FedRAMP, FISMA, and ITAR standards.

Jade operates a freemium-to-subscription model: a free trial converts into recurring subscription revenue from individuals, with emerging coverage from healthcare providers who prescribe the app and payers/insurers who cover it for eligible patients. Go-to-market is primarily product-led via Apple App Store and Google Play self-serve downloads, supplemented by healthcare-provider referrals, content marketing, social media, and email. The platform reports a user base of 25,000-43,000+ people with diabetes globally, with only one disclosed institutional capital event (a 2020 500 Global investment) and a headcount in the 11-50 range.

Jade firmographics

Firmographics
Name
Jade
Legal name
Jade Diabetes Pty Ltd
Website
https://jadediabetes.com
Company type
Private
Founded year
2012
Operating status
Operating
Headcount range
11–50 employees
Short description
Jade Diabetes is a Melbourne-based software company whose mobile app provides AI-driven insulin dose calculations, multi-hour blood-glucose predictions, and personalized coaching for people with insulin-dependent diabetes, integrating with CGMs, food, fitness and health-tracking apps.
Ownership category
akta.pro rank

Jade industry classification

Industry
Product category
Diabetes Management Software
NAICS
Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (5182)
SIC
In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro industry
PRIMARYHLAHAHAJ
Diabetes Digital Therapeutics & Dose Decision Support (Bolus Calculators)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Diabetes Care Devices (CGM, Insulin Delivery)
SECONDARYHLALAGAD
Endocrinology & Diabetes Telemedicine Platforms
Healthcare & Life Sciences/Telehealth Platforms/Specialty Telemedicine Platforms (e.g., dermatology, cardiology, neurology)
SECONDARYHLALAFAF
Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms

Keywords

  • Insulin dose calculation
  • Blood glucose prediction
  • Diabetes management software
  • Continuous glucose monitoring
  • Remote patient monitoring

Where Jade is headquartered

Location

Headquarters

HQ city
Mount Waverley
HQ country
Australia
HQ region
Oceania

Offices1 record

Markets served

Jade business model

Business model
GTM type
B2B and B2C
Offering type
Software
Cost components
Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations

Revenue model

  1. App Subscription (Freemium with Free Trial): The service offers a FREE trial period, followed by subscription-based access to the full Jade Diabetes app with premium features including advanced dose calculations, predictions, coaching, and unlimited device sync. The company generates recurring subscription revenue from individuals, healthcare providers, and payers (insurance companies) who cover the app for patients.

Pricing tiers

ModelBillingPrice
FreemiumMonthlyFree Trial Period

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Jade product offering

Product offering

Core offering

Jade Diabetes provides a smartphone insulin dosing app that calculates insulin doses, predicts blood glucose levels hours ahead (with 87% accuracy up to three hours ahead), and offers coaching for people with insulin-dependent diabetes (Type 1, LADA/Type 1.5, Type 2, Gestational). It integrates live data from continuous glucose monitors (Dexcom, FreeStyle Libre, NightScout), connected glucometers, food apps covering 5 million foods, fitness devices, digital insulin pens, period trackers, and pain trackers. The platform uses the same algorithms as closed-loop artificial pancreas systems but applies them to multiple daily injection therapy, with companion modules for healthcare provider remote patient monitoring (CamperView), Alexa voice control, telehealth, an open developer API, and a points-based gamification system.

Product overview

Jade Diabetes is a unified diabetes management platform centered on a smartphone insulin dosing app (formerly PredictBGL and ManageBGL) that provides dose calculations and blood glucose predictions using closed-loop artificial pancreas algorithms applied to multiple daily injection therapy. The platform operates as a single product with integrated modules including CamperView (Remote Patient Monitoring), an Alexa voice skill, Tele Health consultation support, an Open API for device integrations, a Points System for gamification, and iHealth device connectivity. Available for both iOS and Android smartphones and tablets with live data sync between unlimited devices.

Differentiator

Problem solved

Functional benefit

Brands

  • Jade: Main diabetes management app brand providing insulin dosing calculations, blood glucose predictions, and coaching for people with Type 1, Type 1.5, Type 2, Gestational, and LADA diabetes

Products and services

  • Jade Diabetes App Smartphone insulin dosing app (iOS and Android) for people with insulin-dependent diabetes (Type 1, Type 1.5/LADA, Type 2, Gestational). Provides dose calculations using insulin-on-board tracking, AI-powered blood glucose predictions up to three hours ahead, hypo/hyper alerts, food logging across 5 million foods, coaching with gamification, and live integration with Dexcom, FreeStyle Libre, NightScout, connected glucometers, fitness devices, digital insulin pens, period trackers, and pain trackers via Apple HealthKit.
  • CamperView Remote Patient Monitoring Enterprise remote patient monitoring module that lets healthcare providers, clinics, schools, and camp staff view patient diabetes data live. Supports in-patient, clinic, and school camp care with extensive reporting, population-level statistics, and patient triage capabilities. Targets endocrinologists, diabetes educators, school nurses, and clinicians running diabetes camps.
  • Jade Diabetes Portal Web portal that supports remote patient monitoring and clinical research by healthcare professionals, with extensive reporting, population statistics, and patient triage capabilities. Companion to the mobile app for clinical use cases.
  • Jade API Open developer API that enables import from over 60 diabetic devices and legacy diabetes management systems, and allows developers to build vendor applications integrating mobile health apps and devices. Supports remote patient monitoring and clinical research use cases.

Quantifiable outcome

  • 87% accurate blood glucose predictions up to three hours ahead
  • +2 more outcomes

Companies that use Jade

Customer profile

Named customers4 records

Segments5 records

Ideal customer profiles5 records

Jade technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Integration15 records

AI capability2 records

Feature5 records

Jade partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered core and supporting.

  • DexcomcoreTechnology or IntegrationDexcom CGM integration allowing live blood glucose data streaming into Jade Diabetes. Supports Dexcom G7, G6, G5, G4 with Share. Five-minute blood sugar data is seamlessly integrated for dosing calculations and predictions.
  • Abbott (FreeStyle Libre)coreTechnology or IntegrationFreeStyle Libre CGM integration with support for FreeStyle Libre, FreeStyle Libre 2 using LibreLink. Data seamlessly integrated into the Jade platform for continuous monitoring.
  • NightScoutcoreTechnology or IntegrationNightScout open-source artificial pancreas system integration. Data from the NightScout system is accepted to allow integration with APS (Open Source Artificial Pancreas).
  • Apple HealthcoreTechnology or IntegrationApple Health integration allowing point-in-time data from connected glucometers, fitness devices, food apps, and insulin data sources via HealthKit on iPhone.
  • Amazon AlexacoreTechnology or IntegrationAmazon Alexa voice assistant integration allowing users to manage diabetes with voice commands through the Jade Alexa skill.
  • MyFitnessPalsupportingTechnology or IntegrationFood app integration for precise carbohydrate, protein, fat and fiber data from 5 million foods for accurate dose calculations.
  • CalorieKingsupportingTechnology or IntegrationFood database integration for carbohydrate counting and nutrition data from CalorieKing food database.
  • FatSecretsupportingTechnology or IntegrationFood app integration providing nutrition data integration for meal logging and dose calculations.
  • iHealth (iBG5s)supportingTechnology or IntegrationiHealth iBG5s Bluetooth blood glucose meter integration for wireless data sync with Jade Diabetes app.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Jade competitors and assessment

Company assessment

Direct peers

  • One Drop: Subscription-based diabetes management app with coaching, CGM data integration, and a direct-to-consumer hardware glucometer offering. Competes with Jade for self-pay T1D/T2 insulin users willing to pay for premium features.
  • Glooko: Diabetes data management platform that aggregates data from 95+ devices and serves both consumers and healthcare providers via Mobile Insulin Dosing System (MIDS). Comparable in its multi-device integration strategy and healthcare-provider RPM focus.
  • DarioHealth: Chronic condition management platform with a diabetes-focused product line including connected glucometer hardware, app-based coaching, and B2B payer contracts. Comparable in its subscription-plus-coaching model and employer/payer go-to-market.
  • Tidepool: Nonprofit diabetes data platform supporting multiple pumps and CGMs with clinician-facing analytics. Comparable integration breadth and provider focus, though positioned as a data platform rather than a consumer dose calculator.
  • Sugarmate: Tandem Diabetes Care-owned CGM companion app providing visualization, alerts, and Siri/Tidepool integration. Competes directly with Jade's CGM-data interpretation layer, though lacks Jade's predictive AI bolus engine.
  • mySugr: Diabetes management app offering logging, bolus estimation, and coaching. Acquired by Roche in 2017, it is the most direct competitor in the consumer diabetes dose-tracking space and overlaps heavily with Jade's MDI user base.
  • Diabetes:M: Mobile diabetes management app offering logging, bolus calculation, and reports on iOS/Android. Smaller scale direct peer in the consumer dose-tracking category with comparable freemium model.

Broad incumbents

  • Dexcom: Largest CGM manufacturer with companion apps (Dexcom Clarity, Follow app) that increasingly add dose guidance. As Jade's primary data source, Dexcom is both partner and a potential competitive threat should it extend prediction features natively.
  • Insulet (Omnipod): Leading tubeless insulin pump maker whose Omnipod 5 AID system includes SmartBolus calculator and trend-based dose adjustments. Represents the closed-loop alternative to Jade's MDI positioning and the most direct premium substitute for users who can afford pump therapy.
  • Abbott (FreeStyle Libre): Second-largest CGM manufacturer whose LibreLink app provides glucose data visualization and trend analysis. Similar competitive overlap as Dexcom; LibreLinkUp family app targets the same caregiver use case as Jade's parent-monitoring features.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Jade social profiles

Digital presence

Jade compliance and trust

Trust signal

Compliance13 records

Jade financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Jade leadership team

Management profile

Number of profiles

Profiles1 record

Jade funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Jade M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Jade

What does Jade do?

Jade Diabetes provides a smartphone insulin dosing app that calculates insulin doses, predicts blood glucose levels hours ahead (with 87% accuracy up to three hours ahead), and offers coaching for people with insulin-dependent diabetes (Type 1, LADA/Type 1.5, Type 2, Gestational). It integrates live data from continuous glucose monitors (Dexcom, FreeStyle Libre, NightScout), connected glucometers, food apps covering 5 million foods, fitness devices, digital insulin pens, period trackers, and pain trackers. The platform uses the same algorithms as closed-loop artificial pancreas systems but applies them to multiple daily injection therapy, with companion modules for healthcare provider remote patient monitoring (CamperView), Alexa voice control, telehealth, an open developer API, and a points-based gamification system.

Is Jade a public or private company?

Jade is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Jade founded?

Jade was founded in 2012. It employs 11 to 50 people.

Where is Jade based?

Jade is headquartered in Mount Waverley, Australia, in the Oceania region.

How does Jade make money?

One revenue line is on record: app Subscription (Freemium with Free Trial).

Who are Jade's main competitors?

Direct peers on record are One Drop, Glooko, DarioHealth, Tidepool, Sugarmate, mySugr and Diabetes:M. Broad incumbents are Dexcom, Insulet (Omnipod) and Abbott (FreeStyle Libre).

Does Jade have an API?

Yes. Jade provides an Open API that allows import capability from over 60 diabetic devices, legacy diabetes management systems, and allows developers to create vendor applications for integrating mobile health apps and devices. The API supports remote patient monitoring and research by Health Care Professionals. Developer documentation is at www.jadediabetes.com/api.

What industry is Jade in?

Jade's product category is Diabetes Management Software. Its primary akta.pro industry code is HLAHAHAJ, Diabetes Digital Therapeutics & Dose Decision Support (Bolus Calculators), with a secondary code of HLALAGAD, Endocrinology & Diabetes Telemedicine Platforms. Its NAICS code is 5182 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales